Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Omada Health, Inc. (OMDA : NSDQ)

• Company Description    Omada Health Inc. provides a range of virtual care programs principally in the United States. The company offers cardiometabolic programs for prediabetes, diabetes and hypertension; a physical therapy program to address musculoskeletal conditions other support programs. Omada Health Inc. is based in San Francisco, California. Number of Employees: 916

• Price / Volume Information    Yesterday's Closing Price: $16.51 Daily Weekly Monthly 20 Day Moving Average: 1,224,643 shares Shares Outstanding: 59.45 (millions) Market Capitalization: $981.50 (millions) Beta: 52 Week High: $28.40 52 Week Low: $10.28 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 16.10% 10.43% 12 Week 27.49% 17.86% Year To Date 4.63% -4.22%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 611 Gateway Blvd Suite 120 - South San Francisco,CA 94080 USA ph: 888-987-8337 fax: - ir@omadahealth.com http://www.omadahealth.com

• General Corporate Information    Officers Sean Duffy - Chief Executive Officer and Director Steve Cook - Chief Financial Officer Jeryl Hilleman - Director Anne Beal - Director Trevor Fetter - Director Peer Information Omada Health, Inc. (CHCR) Omada Health, Inc. (ESRX) Omada Health, Inc. (MYDP) Omada Health, Inc. (COR) Omada Health, Inc. (GBCS) Omada Health, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 68170A108 SIC: 8000 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/06/26 Share - Related Items Shares Outstanding: 59.45 Most Recent Split Date: (:1) Beta: Market Capitalization: $981.50 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.01 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.04 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 4.19 Price/Cash Flow: - Price / Sales: 3.46 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -162.50% Sales Growth vs. Year Ago Period: 42.00% vs. Previous Quarter: 2.90% ROE 03/31/26 - -1.82 12/31/25 - -6.44 09/30/25 - - ROA 03/31/26 - -1.36 12/31/25 - -4.75 09/30/25 - - Current Ratio 03/31/26 - 3.92 12/31/25 - 3.60 09/30/25 - 3.63 Quick Ratio 03/31/26 - 3.87 12/31/25 - 3.54 09/30/25 - 3.59 Operating Margin 03/31/26 - -1.44 12/31/25 - -4.09 09/30/25 - - Net Margin 03/31/26 - -2.22 12/31/25 - -4.91 09/30/25 - - Pre-Tax Margin 03/31/26 - -2.22 12/31/25 - -4.91 09/30/25 - - Book Value 03/31/26 - 3.94 12/31/25 - 3.97 09/30/25 - 3.78 Inventory Turnover 03/31/26 - 25.60 12/31/25 - 32.16 09/30/25 - - Debt-to-Equity 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - 0.00 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©